Market Cap 190.40M
Revenue (ttm) 40.37M
Net Income (ttm) -119.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -296.56%
Debt to Equity Ratio 0.00
Volume 292,600
Avg Vol 515,626
Day's Range N/A - N/A
Shares Out 61.62M
Stochastic %K 27%
Beta 1.32
Analysts Strong Sell
Price Target $15.38

Company Profile

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neu...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 259 5340
Address:
75 Hayden Avenue, Lexington, United States
RoseCox1025
RoseCox1025 Sep. 21 at 10:35 PM
$VYGR Strong preclinical data Up to 75% tau reduction in primate studies🚀
0 · Reply
JuggernautRaider
JuggernautRaider Sep. 18 at 3:03 PM
$CGTX $TLSA $VYGR i love them all and keep buying dips! 🧠 beep beep @Biotech_Beast beep beep @Night_Owl_Biotech and hey you @Proposition_Joe BEEP BEEP $TNXP is undervalued too move over 🛻
0 · Reply
ASTANA
ASTANA Sep. 17 at 7:27 PM
$VYGR $RARE ULTRAGENYX PHARMACEUTICAL APPROVAL — First gene therapy for Sanfilippo syndrome type A approved for pediatric patients Why it matters: AAV9 validates pediatric CNS gene delivery. Signal: 🟢 BULLISH
0 · Reply
BluntForceOptions
BluntForceOptions Sep. 9 at 11:52 PM
$VYGR Five fireside chats in eight days. Wells Fargo (done), Cantor Friday, Morgan Stanley Monday, Baird and Wainwright Tuesday. Schedule below for anyone tracking it. Worth being clear about what this is and isn't: fireside chats are management talking, not data. Nothing here is a catalyst. But I've been in and out of this name recently and I'm watching what they say about timing, so a few thoughts. The only thing that matters out of these is whether Q4 tau PET timing gets narrowed, repeated, or quietly widened into early 2027. That last one, IMO, is the risk nobody's pricing. Closed the trade, still watching, not chasing. Put this one on in late July with the stock right at $3.00. Sold the $3 puts into fat IV, took it off north of $3.50 for better than half the premium. Limit order filled and I was fine killing the duration risk rather than grinding out the last third. Stock never broke $3 the whole time. Just chopped between 3.00 and 3.50 and paid me to wait. Why I still care: Tau is the most interesting target in Alzheimer's right now, and Voyager has two shots at it -- the VY7523 antibody and the VY1706 gene therapy. • $149M in the bank at Q2 • Runway into 2028 • North of $500M in non-dilutive partner money to date from Neurocrine, Novartis and Alexion They're not out begging for a raise, which is more than most $200M biotechs can say. Why I'm not back in yet: The real binary is Q4 tau PET. Company hasn't named a venue, but CTAD runs Nov 16–19 in Boston and that's where they dropped the last dataset. Everything between here and there is noise. Chart isn't helping either: • Under the 50, 100 and 200 day • ADX at 11 • Stochastic rolling over off 80 No trend, just chop. And the broader biotech tape is getting taken behind the woodshed. Alzheimer's is a graveyard indication. Most of these die. But the ones that work don't go up 40%... they go up multiples. That's the whole reason to be here, and it's also the reason to size it like you might be wrong. Patience is free. I'll see how this develops over the coming weeks. Stay tuned. Please do your own DD and check everything. NFA.
0 · Reply
tumanako
tumanako Sep. 7 at 10:02 AM
0 · Reply
BiotechButterflies
BiotechButterflies Sep. 2 at 4:51 PM
$VYGR ... positioned readt for late 26 data and progress... a nive value still
0 · Reply
SeamsOF
SeamsOF Aug. 31 at 8:56 AM
$TNXP $VYGR $CGTX $IXHL Resonating narrative Mechanism of action OSA FDA AND PSI GAD Pathways Hi From Dubai
0 · Reply
SeamsOF
SeamsOF Aug. 30 at 3:28 AM
$TNXP $VYGR $CGTX $IXHL You know you have cracked it on ST when your ticker gets inserted into the ramblings of a God botherer 1600% Chance of Breath just Breathe Pathways
0 · Reply
TheUnmaker
TheUnmaker Aug. 29 at 10:21 PM
$TNXP $VYGR $CGTX $IXHL "Am I in your mother?" And then you'll post a religious scripture and how holy and righteous you are about family. Thanks bro, I wasn't expecting this but are these your true colors?
2 · Reply
JuggernautRaider
JuggernautRaider Aug. 29 at 10:17 PM
$TNXP $VYGR $CGTX $IXHL 🤕 🧠 🧬 🇦🇺 🇺🇸 Why does it matter what “I am in”? 🍆 Why should I tell you a think? 🤠 Am I in your mother? No? Ok then. 🇺🇸
2 · Reply
Latest News on VYGR
Voyager to Present at Upcoming Investor Conferences

Sep 1, 2026, 8:00 AM EDT - 20 days ago

Voyager to Present at Upcoming Investor Conferences


Voyager Therapeutics reports Q2 EPS (40c), consensus (51c)

2026-08-06T20:37:47.000Z - 6 weeks ago

Voyager Therapeutics reports Q2 EPS (40c), consensus (51c)


Voyager Therapeutics Quarterly report: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 6 weeks ago

Voyager Therapeutics Quarterly report: Q2 2026


Voyager Therapeutics Earnings release: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 6 weeks ago

Voyager Therapeutics Earnings release: Q2 2026


Voyager Therapeutics Transcript: AGM 2026

Jun 9, 2026, 9:00 AM EDT - 3 months ago

Voyager Therapeutics Transcript: AGM 2026


Voyager Therapeutics reports Q1 EPS (47c), consensus (53c)

2026-05-07T21:41:13.000Z - 4 months ago

Voyager Therapeutics reports Q1 EPS (47c), consensus (53c)


Voyager Therapeutics Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Voyager Therapeutics Quarterly report: Q1 2026


Voyager Therapeutics Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Voyager Therapeutics Earnings release: Q1 2026


Voyager Therapeutics management to meet with Oppenheimer

2026-04-28T12:55:45.000Z - 4 months ago

Voyager Therapeutics management to meet with Oppenheimer


Voyager Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Voyager Therapeutics Proxy statement: Proxy filing


Voyager Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Voyager Therapeutics Proxy statement: Proxy filing


Voyager Therapeutics management to meet with Oppenheimer

2026-04-10T20:55:57.000Z - 5 months ago

Voyager Therapeutics management to meet with Oppenheimer


Voyager Therapeutics Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 5 months ago

Voyager Therapeutics Proxy statement: Proxy filing


Voyager Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 18, 2026, 12:30 PM EDT - 6 months ago

Voyager Therapeutics Transcript: Stifel 2026 Virtual CNS Forum


Voyager Therapeutics reports Q4 EPS (46c), consensus (51c)

2026-03-09T20:10:45.000Z - 6 months ago

Voyager Therapeutics reports Q4 EPS (46c), consensus (51c)


Voyager Therapeutics Earnings release: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 6 months ago

Voyager Therapeutics Earnings release: Q4 2025


Voyager Therapeutics Annual report: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 6 months ago

Voyager Therapeutics Annual report: Q4 2025


Voyager Therapeutics Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 3:20 PM EST - 10 months ago

Voyager Therapeutics Transcript: Stifel 2025 Healthcare Conference


Voyager Therapeutics files $400M mixed securities shelf

2025-11-10T21:10:18.000Z - 10 months ago

Voyager Therapeutics files $400M mixed securities shelf


Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)

2025-11-10T13:17:23.000Z - 10 months ago

Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)


Voyager Therapeutics expects cash to fund operations into 2028

2025-11-10T13:17:10.000Z - 10 months ago

Voyager Therapeutics expects cash to fund operations into 2028


Voyager Reports Third Quarter 2025 Financial and Operating Results

Nov 10, 2025, 8:01 AM EST - 10 months ago

Voyager Reports Third Quarter 2025 Financial and Operating Results


Voyager Therapeutics Earnings release: Q3 2025

Nov 10, 2025, 8:00 AM EST - 10 months ago

Voyager Therapeutics Earnings release: Q3 2025


Voyager Therapeutics Quarterly report: Q3 2025

Nov 10, 2025, 8:00 AM EST - 10 months ago

Voyager Therapeutics Quarterly report: Q3 2025


Voyager Therapeutics Registration statement: Registration Filing

Nov 10, 2025, 7:00 AM EST - 10 months ago

Voyager Therapeutics Registration statement: Registration Filing


Voyager Therapeutics reports Q2 EPS (57c), consensus (52c)

2025-08-06T20:33:20.000Z - 1 year ago

Voyager Therapeutics reports Q2 EPS (57c), consensus (52c)


Voyager Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Voyager Therapeutics Quarterly report: Q2 2025


Voyager Therapeutics Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Voyager Therapeutics Earnings release: Q2 2025


Voyager Therapeutics continues expansion of its AD franchise

2025-07-16T11:06:32.000Z - 1 year ago

Voyager Therapeutics continues expansion of its AD franchise


Voyager Therapeutics Quarterly report: Q1 2025

May 6, 2025, 4:00 PM EDT - 1 year ago

Voyager Therapeutics Quarterly report: Q1 2025


Voyager Therapeutics Earnings release: Q1 2025

May 6, 2025, 4:00 PM EDT - 1 year ago

Voyager Therapeutics Earnings release: Q1 2025


Voyager Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Voyager Therapeutics Proxy statement: Proxy Filing


Voyager Therapeutics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Voyager Therapeutics Proxy statement: Proxy Filing


Voyager Therapeutics Transcript: Virtual CNS Forum

Mar 19, 2025, 11:00 AM EDT - 1 year ago

Voyager Therapeutics Transcript: Virtual CNS Forum


Voyager Therapeutics Earnings Call Transcript: Q4 2024

Mar 11, 2025, 4:30 PM EDT - 1 year ago

Voyager Therapeutics Earnings Call Transcript: Q4 2024


Voyager Therapeutics Annual report: Q4 2024

Mar 11, 2025, 4:30 PM EDT - 1 year ago

Voyager Therapeutics Annual report: Q4 2024


Voyager Therapeutics Earnings release: Q4 2024

Mar 11, 2025, 4:30 PM EDT - 1 year ago

Voyager Therapeutics Earnings release: Q4 2024


Voyager Provides Update on SOD1 ALS Gene Therapy Program

Feb 11, 2025, 7:00 AM EST - 1 year ago

Voyager Provides Update on SOD1 ALS Gene Therapy Program


Voyager Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Voyager Therapeutics Earnings Call Transcript: Q3 2024


Voyager Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Voyager Therapeutics Quarterly report: Q3 2024


Voyager Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Voyager Therapeutics Earnings release: Q3 2024


Voyager Therapeutics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Voyager Therapeutics Earnings Call Transcript: Q2 2024


Voyager Therapeutics Quarterly report: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Voyager Therapeutics Quarterly report: Q2 2024


Voyager Therapeutics Earnings release: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Voyager Therapeutics Earnings release: Q2 2024


Voyager Therapeutics Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Voyager Therapeutics Earnings Call Transcript: Q1 2024


Voyager Therapeutics Quarterly report: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Voyager Therapeutics Quarterly report: Q1 2024


Voyager Therapeutics Earnings release: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Voyager Therapeutics Earnings release: Q1 2024


RoseCox1025
RoseCox1025 Sep. 21 at 10:35 PM
$VYGR Strong preclinical data Up to 75% tau reduction in primate studies🚀
0 · Reply
JuggernautRaider
JuggernautRaider Sep. 18 at 3:03 PM
$CGTX $TLSA $VYGR i love them all and keep buying dips! 🧠 beep beep @Biotech_Beast beep beep @Night_Owl_Biotech and hey you @Proposition_Joe BEEP BEEP $TNXP is undervalued too move over 🛻
0 · Reply
ASTANA
ASTANA Sep. 17 at 7:27 PM
$VYGR $RARE ULTRAGENYX PHARMACEUTICAL APPROVAL — First gene therapy for Sanfilippo syndrome type A approved for pediatric patients Why it matters: AAV9 validates pediatric CNS gene delivery. Signal: 🟢 BULLISH
0 · Reply
BluntForceOptions
BluntForceOptions Sep. 9 at 11:52 PM
$VYGR Five fireside chats in eight days. Wells Fargo (done), Cantor Friday, Morgan Stanley Monday, Baird and Wainwright Tuesday. Schedule below for anyone tracking it. Worth being clear about what this is and isn't: fireside chats are management talking, not data. Nothing here is a catalyst. But I've been in and out of this name recently and I'm watching what they say about timing, so a few thoughts. The only thing that matters out of these is whether Q4 tau PET timing gets narrowed, repeated, or quietly widened into early 2027. That last one, IMO, is the risk nobody's pricing. Closed the trade, still watching, not chasing. Put this one on in late July with the stock right at $3.00. Sold the $3 puts into fat IV, took it off north of $3.50 for better than half the premium. Limit order filled and I was fine killing the duration risk rather than grinding out the last third. Stock never broke $3 the whole time. Just chopped between 3.00 and 3.50 and paid me to wait. Why I still care: Tau is the most interesting target in Alzheimer's right now, and Voyager has two shots at it -- the VY7523 antibody and the VY1706 gene therapy. • $149M in the bank at Q2 • Runway into 2028 • North of $500M in non-dilutive partner money to date from Neurocrine, Novartis and Alexion They're not out begging for a raise, which is more than most $200M biotechs can say. Why I'm not back in yet: The real binary is Q4 tau PET. Company hasn't named a venue, but CTAD runs Nov 16–19 in Boston and that's where they dropped the last dataset. Everything between here and there is noise. Chart isn't helping either: • Under the 50, 100 and 200 day • ADX at 11 • Stochastic rolling over off 80 No trend, just chop. And the broader biotech tape is getting taken behind the woodshed. Alzheimer's is a graveyard indication. Most of these die. But the ones that work don't go up 40%... they go up multiples. That's the whole reason to be here, and it's also the reason to size it like you might be wrong. Patience is free. I'll see how this develops over the coming weeks. Stay tuned. Please do your own DD and check everything. NFA.
0 · Reply
tumanako
tumanako Sep. 7 at 10:02 AM
0 · Reply
BiotechButterflies
BiotechButterflies Sep. 2 at 4:51 PM
$VYGR ... positioned readt for late 26 data and progress... a nive value still
0 · Reply
SeamsOF
SeamsOF Aug. 31 at 8:56 AM
$TNXP $VYGR $CGTX $IXHL Resonating narrative Mechanism of action OSA FDA AND PSI GAD Pathways Hi From Dubai
0 · Reply
SeamsOF
SeamsOF Aug. 30 at 3:28 AM
$TNXP $VYGR $CGTX $IXHL You know you have cracked it on ST when your ticker gets inserted into the ramblings of a God botherer 1600% Chance of Breath just Breathe Pathways
0 · Reply
TheUnmaker
TheUnmaker Aug. 29 at 10:21 PM
$TNXP $VYGR $CGTX $IXHL "Am I in your mother?" And then you'll post a religious scripture and how holy and righteous you are about family. Thanks bro, I wasn't expecting this but are these your true colors?
2 · Reply
JuggernautRaider
JuggernautRaider Aug. 29 at 10:17 PM
$TNXP $VYGR $CGTX $IXHL 🤕 🧠 🧬 🇦🇺 🇺🇸 Why does it matter what “I am in”? 🍆 Why should I tell you a think? 🤠 Am I in your mother? No? Ok then. 🇺🇸
2 · Reply
Monludo06
Monludo06 Aug. 29 at 1:11 PM
$CGTX $IXHL $SLS $VYGR Advisors rarely foot the bill... you sold SLS at the same price as today; NUVB has gained over 19% since you sold, and TLSA has lost over 19% since you bought. Anyway, to each their own, but why give "advice"?
1 · Reply
JuggernautRaider
JuggernautRaider Aug. 29 at 12:49 PM
Eh i bought a ton of $SLS from $1.50 to $2 and sold it all above $15 a while ago I needed the cash to invest elsewhere 😉 A good 10x? Why would you hold? AML is a tiny but brutal disease. What is your thesis for holding after I made 900%? 🧐 $CGTX $IXHL and $VYGR oh my 🐅 ROAR 🦁 🐯 😈
4 · Reply
JuggernautRaider
JuggernautRaider Aug. 27 at 8:36 AM
$AVXL sad but predictable! IKYKW 🧠 Heavy into $TNXP $CGTX and of course $VYGR plus TLSA as my neuroscience plays long 🚀 🤷‍♂️ 🙏 🤕
0 · Reply
JuggernautRaider
JuggernautRaider Aug. 26 at 7:57 PM
$CGTX @Biopharma15 @Biotech_Beast @Biopharma2021 @Proposition_Joe @PeteyUSA Owe I agree. I’ve quietly accumulated 10K shares of CGTX. Also buying up $VYGR and $TLSA Sell $TSLA it is a DOG 🐶 ⚡️ 🪦
1 · Reply
JuggernautRaider
JuggernautRaider Aug. 26 at 5:19 PM
$NGEN $CGTX $TLSA $VYGR ooowwee! Tell me more 🐷 🧠 😋
2 · Reply
JuggernautRaider
JuggernautRaider Aug. 26 at 10:13 AM
$VYGR $TLSA $CGTX $ABOS these are my favorite four cognitive biotechs. Given I played football and have mild CTE and likely early onset Parkinson’s… i want to get more into neuroscience biotechs. Which am I missing? I keep studying the sector and these are my core four. Thanks! 🧠 💨 💊 💉 😯 🧫 😊 🦴 🍴 The BONESAW OF bioTech ~ thee Jay Sizzled 🎶
3 · Reply
tumanako
tumanako Aug. 25 at 11:26 PM
0 · Reply
tumanako
tumanako Aug. 25 at 11:25 PM
0 · Reply
tumanako
tumanako Aug. 22 at 2:03 AM
$VYGR have not seen many clusters of bullish divergence since last November. Bring on the good news
0 · Reply
ASTANA
ASTANA Aug. 18 at 7:44 PM
0 · Reply
ASTANA
ASTANA Aug. 18 at 7:41 PM
$VYGR tracer
0 · Reply
tumanako
tumanako Aug. 16 at 8:33 AM
$VYGR Bollinger Band sits well inside Keltner Channel, typical squeeze. Just wait for the squeeze to release, wheter to upside or downside. So far, no red bar appears. Keep finger crossed until the clinical trial results out.
0 · Reply